Volume 51 - Issue 11 - November, 2005

Column

Editorial

Editor`s Opinion: Protecting Science: A Word Warrior Alert

11/01/2005

US pharmaceutical companies were not always allowed to advertise directly to consumers. The moment they could, they sought the skills of advertising agencies adept at developing slogans and catchy phrases and applying new words to...

US pharmaceutical companies...

11/01/2005

Wound Management & Prevention

Department

Letters to the Editor

11/01/2005

Dear Editor, In the article on the use of Hydrovase (Swiss-American Products, Inc., Dallas, Tex.) (Parnell LKS, Ciufi B, Gokoo CF. Preliminary use of a hydrogel containing enzymes in the treatment of Stage II and Stage III pressure...

Dear Editor, In the article...

11/01/2005

Wound Management & Prevention

Department

Autumnal Announcements

11/01/2005

GAO Evaluates FDA Performance on Medical Device Review Process The US Food and Drug Administration (FDA) must review all applications for new medical devices. Manufacturers of medical devices have long complained about the arduous and...

GAO Evaluates FDA Performance on...

11/01/2005

Wound Management & Prevention

Feature

Case Report

Using a Dermal Skin Substitute in the Treatment of Chronic Wounds Secondary to Recessive Dystrophic Epidermolysis Bullosa: A Case Series

11/01/2005

The term Epidermolysis bullosa (EB) has been used since 1886 to identify a form of hereditary blistering disease and today is commonly used to describe a family of genetic disorders that cause blistering and shearing of the skin from even...

The term Epidermolysis...

11/01/2005

Wound Management & Prevention